AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 DEC 18 - (NewsRx.com & NewsRx.net) -- by Maria G. Essig, MS, ELS, senior medical writer - Many head and neck tumors were found to express human carcinoembryonic antigen (CEA), providing a potential target for vaccine therapy of head and neck cancers (HNC).
Overexpression of CEA by gastrointestinal carcinomas has been widely studied. However, investigations into its expression by head and neck tumors are lacking. Erik S. Kass and colleagues at the U.S. National Institutes of Health evaluated the expression of CEA by squamous cell carcinomas of the head and neck and the potential for vaccine therapy directed against CEA for treatment of head and neck cancers.
The investigators performed immunohistochemical analyses of 69 squamous cell carcinoma tumors using a monoclonal antibody (COL-1) specific for CEA and found that most of the tumor samples were CEA-positive, although cell surface expression was low.
Reverse transcription PCR revealed CEA expression in 7 out of 10 human HNC cell lines. Detection of the CEA protein was possible in the lysates from all 7 of the cell lines that expressed the antigen. SDS-PAGE combined with Western blot analysis of the 7 CEA-positive cell lines demonstrated the presence of an agent that possessed the same molecular weight as CEA and reacted with COL-1. Cytoplasmic staining intensity of the cells was moderate to strong in the 7 CEA-positive cell ...